✦ LIBER ✦

Current Treatment in Advanced Renal Cell Carcinoma (RCC): Impact of Targeted Therapies in the Management of RCC

✍ Scribed by Joaquim Bellmunt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of angiogenic and non-angioge

✍ Yuen, J S P; Sim, M Y; Siml, H G; Chong, T W; Lau, W K O; Cheng, C W S; Huynh, H 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 628 KB

Prognostic factors in the T3 category of

✍ C. Terrone; S. Guercio; S. De Luca; E. Castelli; M. Poggio; C. Scoffone; R. Tara 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Management of metastatic renal cell carc

✍ K. Webber; A. Cooper; H. Kleiven; D. Yip; D. Goldstein 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

PUK15 COST IMPLICATIONS OF INTRAVENOUS (

✍ AA Fournier; MS Duh; É Moyneur; E Dial; MP Neary; WK Oh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

916Temozolomide in the management of pro

✍ A. Heidenreich; C. Ohlmann; G. Haupt; U. Engelmann 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Multidisciplinary management of metastat

✍ Bernard Escudier; Susanne Osanto; Börje Ljungberg; Camillo Porta; John Wagstaff; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 181 KB